Magic power of phosphoinositide 3-kinase inhibitors

  • Xian Wang
Keywords: phosphoinositide 3-kinase inhibitors


Abstract: Phosphoinositide 3-kinases (PI3K) play critical roles in the maintenance of cell biological functions and are suggested as a therapeutic target for drug discovery and development. PI3K inhibitors has the magic power to prevent the development of pathological changes and cure the diseases, while such magic powers can be faded by the large profile of their toxicity and sideeffects. A number of strategies can prevent, reduce, or decline PI3K inhibitor-associated toxicities, e.g. to make the inhibitors targeting the core molecules more precisely, select the optimal approach of drug delivery, bind the “recognizing” pullets with PI3K inhibitors to target-specific cells, or gene editing. We spotlight that PI3K definitely is an important therapeutic targets for cancer, inflammation, or organ dysfunction and injury, while to catch and hold such magic power of PI3K inhibitors is still the challenge to be faced and solved.



Download data is not yet available.

Author Biography

Xian Wang

Bio here



Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K Pathway in Human Disease. Cell. 2017 Aug 10;170(4):605-635.

d e W e e r d t I , K o o p m a n s S M , K a t e r A P, van Gelder M. Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach. Haematologica. 2017 Aug 3 . pii: haematol. 2017 . 164103 . doi: 10 . 3324 / haematol.2017.164103.

Shi B, Deng Y, Zhao P, Li X.Selecting a DNA- Encoded Chemical Library against Non-immobilized Proteins Using a "Ligate-Cross-Link-Purify" Strategy. Bioconjug Chem. 2017 Aug 10. doi: 10.1021/acs. bioconjchem.7b00343.

Massacesi C, Di Tomaso E, Urban P, et al. PI3K inhibitors as new cancer therapeutics: implications for clinical trial design.Onco Targets Ther. 2016 Jan 7;9:203-10.

Chen CS, Fang XC, Wang YL, Li YP, Wang D, Zhao X, Bai CX, Wang XD. Preventive and therapeutic effects of phosphoinositide 3-kinase inhibitors on acute lung injury. Chest. 2011 Aug;140(2):391-400.

Fang X, Li K, Tao X, Chen C, Wang X, Wang L, Wang DC, Zhang Y, Bai C, Wang XD. Effects of phosphoinositide 3-kinase on protease-induced acute

Research Article